Our experience with the treatment of malignant liver tumours

Varování

Publikace nespadá pod Fakultu sportovních studií, ale pod Lékařskou fakultu. Oficiální stránka publikace je na webu muni.cz.
Autoři

LEYPOLD Jindřich PISKAČ Petr

Rok publikování 2002
Druh Článek ve sborníku
Konference Mini-Invasive approach to Cancer
Fakulta / Pracoviště MU

Lékařská fakulta

Citace
Obor Chirurgie včetně transplantologie
Klíčová slova malignant liver tumuors - prognostic factors surgical treatment
Popis In complex oncologic treatment, liver resections play a very important role. Their techique is elaborated. Nowadays, the development focuses on miniinvasive treatment modalities and improvement of hemotherapy regimens. The aim of the paper is the presentation of experience of our surgical department. In the time period from 1988 to 2001, 198 patients with malignant liver tumours were operated on in the 2nd Department of Surgery in Brno. There were 132 resections. In 58 patients, a catheter for regional chemotherapy was inserred, either as a palliative intervention, or for adjuvant chemotherapy after resection. In the last 4 years, the in-hospital mortality rate after liver resections was 2%. The median survival of patents after resection of primary liver tumours was 36 months, after resection of liver metastases 34 months, and among pareints treated with regional chemotherapy 17 months.
Související projekty:

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.

Další info